Open-label study in healthy subjects evaluating steady-state pharmacokinetic interactions between daclatasvir and tenofovir disoproxil fumarate
Phase of Trial: Phase I
Latest Information Update: 20 Aug 2013
At a glance
- Drugs Daclatasvir (Primary) ; Tenofovir disoproxil fumarate
- Indications Hepatitis C; HIV infections
- Focus Pharmacokinetics
- 16 Mar 2012 New trial record
- 08 Mar 2012 Results presented at the 19th Conference on Retroviruses and Opportunistic Infections.
- 08 Mar 2012 Data were presented at the 19th Conference on Retroviruses and Opportunistic Infections (CROI) [Poster Number 618], according to a Bristol-Myers Squibb media release.